Department of Cardiology, Alfred Hospital, 55 Commercial Road, Melbourne, VIC 3004, Australia; Department of Medicine, Nursing and Health Sciences, Monash University, Wellington Road, Clayton, Melbourne, VIC 3168, Australia; Heart Failure Research Group, Baker Heart and Diabetes Institute, 75 Commercial Road, Melbourne, VIC 3004, Australia. Electronic address: https://twitter.com/DrNanayakkara.
Department of Cardiology, Alfred Hospital, 55 Commercial Road, Melbourne, VIC 3004, Australia; Department of Medicine, Nursing and Health Sciences, Monash University, Wellington Road, Clayton, Melbourne, VIC 3168, Australia; Heart Failure Research Group, Baker Heart and Diabetes Institute, 75 Commercial Road, Melbourne, VIC 3004, Australia.
Interv Cardiol Clin. 2020 Jul;9(3):395-401. doi: 10.1016/j.iccl.2020.02.005. Epub 2020 May 7.
Contrast-induced acute kidney injury is not uncommon after percutaneous coronary intervention, particularly in high-risk patients. Pharmacologic approaches have not demonstrated significant benefit, and numerous device-based approaches exist targeting a variety of pathways. In this review, we summarize the most recent interventions and the evidence behind them.
经皮冠状动脉介入治疗后对比剂诱导的急性肾损伤并不少见，特别是在高危患者中。药物治疗方法并未显示出显著的益处，并且存在许多针对各种途径的基于器械的方法。在这篇综述中，我们总结了最新的干预措施及其背后的证据。
